aTyr Pharma Gets $20M Credit Facility

San Diego-based biotherapeutics developer aTyr Pharma announced this morning that it has received a $20M credit facility. The credit facility came from Silicon Valley Bank and Solar Capital Ltd. Terms of that credit facility were not announced. The company said it will use the funding to pay off existing indebtedness and for general corporate purposes. aTyr Pharma is developing therapeutics addresses severe and rare diseases related to muscular dystrophy and other areas.